Figure 1.
Risk of early vomiting by antimalarial use and day of observation (cumulative risk: artemether-lumefantrine = 7.1%, dihydroartemisinin-piperaquine = 15.1%; P = 0.007).
Risk of early vomiting by antimalarial use and day of observation (cumulative risk: artemether-lumefantrine = 7.1%, dihydroartemisinin-piperaquine = 15.1%; P = 0.007).